You Ji Young, Kim Young Min, Lee Eun-Shin, Lee Haemin, Jung Seung Pil
Division of Breast and Endocrine Surgery, Department of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul 02841, Republic of Korea.
Department of General Surgery, Inseong Medical Foundation Hallym Hospital, Incheon 14441, Republic of Korea.
J Clin Med. 2025 Jun 29;14(13):4608. doi: 10.3390/jcm14134608.
: A surgical therapy for breast cancer, robot-assisted nipple-sparing mastectomy (RANSM) has gained popularity because it may offer better cosmetic results than traditional nipple-sparing mastectomy (CNSM). Data regarding RANSM's viability and security are still scarce, nevertheless. Comparing the surgical results of RANSM and CNSM in a single-center experience was the goal of this study. : 57 patients who had nipple-sparing mastectomy procedures performed at our facility between January and December 2021 were included in this retrospective research. Of them, 49 patients had CNSM, and 8 patients had RANSM. Analysis was performed on pain scores, length of hospital stay, postoperative complications, patient demographics, and operating time. : The mean total operative time was longer for RANSM group was 148 min compared to 117 min for the CNSM group; however, this difference was not statistically significant ( = 0.083). The mean duration of hospital stay was shorter for the RANSM group than for the CNSM group (10.75 days vs. 2.92 days, respectively; = 0.302). Both groups had similar pain scores on postoperative day 3 (RANSM: 3.50, CNSM: 3.54, = 0.926). No patient in the RANSM group received adjuvant chemotherapy or radiotherapy, whereas 32.6% of patients in the CNSM group received chemotherapy. The RANSM and CNSM groups experienced complications at rates of 12.5% and 18.4%, respectively ( = 0.571). In contrast to 14.3% in the CNSM group, there were no documented incidences of skin necrosis in the RANSM group. : RANSM demonstrated comparable safety to CNSM with potential benefits, including a shorter hospital stay and lower complication rates. These findings support the feasibility of RANSM, particularly in patients prioritizing cosmetic outcomes. To validate these initial findings, more research with larger cohorts and longer follow-up times is necessary.
作为一种乳腺癌手术治疗方法，机器人辅助保留乳头乳房切除术（RANSM）越来越受欢迎，因为它可能比传统的保留乳头乳房切除术（CNSM）提供更好的美容效果。然而，关于RANSM的可行性和安全性的数据仍然很少。本研究的目的是比较单中心经验中RANSM和CNSM的手术结果。：本回顾性研究纳入了2021年1月至12月在我们机构接受保留乳头乳房切除术的57例患者。其中，49例患者接受了CNSM，8例患者接受了RANSM。对疼痛评分、住院时间、术后并发症、患者人口统计学和手术时间进行了分析。：RANSM组的平均总手术时间较长，为148分钟，而CNSM组为117分钟；然而，这种差异无统计学意义（P = 0.083）。RANSM组的平均住院时间比CNSM组短（分别为10.75天和2.92天；P = 0.302）。两组术后第3天的疼痛评分相似（RANSM：3.50，CNSM：3.54，P = 0.926）。RANSM组没有患者接受辅助化疗或放疗，而CNSM组有32.6%的患者接受了化疗。RANSM组和CNSM组的并发症发生率分别为12.5%和18.4%（P = 0.571）。与CNSM组的14.3%相比，RANSM组没有记录到皮肤坏死的病例。：RANSM显示出与CNSM相当的安全性，并具有潜在的益处，包括住院时间更短和并发症发生率更低。这些发现支持了RANSM的可行性，特别是对于优先考虑美容效果的患者。为了验证这些初步发现，有必要进行更多的大样本队列研究和更长随访时间的研究。
